Core Viewpoint - The article highlights the significant advancements in Beijing's biopharmaceutical industry, particularly through the case study of Gene Enlightenment, which has made strides in developing iNKT cell therapies, showcasing the city's commitment to high-quality development and innovation in the "14th Five-Year Plan" period and beyond [1][10]. Group 1: Company Overview - Gene Enlightenment is pioneering the development of iNKT cell therapies, marking itself as the first company globally to systematically pursue this path, despite the challenges and uncertainties involved [2][5]. - The company has established a robust research and production center in Beijing's Daxing Biopharmaceutical Base, which has facilitated its development process through a supportive industrial ecosystem [6][8]. Group 2: Technological Challenges and Innovations - The primary challenge faced by Gene Enlightenment was the in vitro expansion of iNKT cells, which are present in very low quantities in human blood, necessitating a stable and effective cultivation process [6][7]. - The company has successfully developed a proprietary cell preparation process and quality control system, leading to the initiation of clinical trials for its cell products targeting late-stage liver and pancreatic cancers [7][12]. Group 3: Industry Ecosystem and Support - The Daxing Biopharmaceutical Base provides a collaborative environment with numerous contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs), which are essential for the various stages of drug development [8][9]. - The concentration of talent and resources in Beijing, along with a stable policy environment, has been crucial for the long-term success of innovative companies like Gene Enlightenment [9][12]. Group 4: Future Prospects and Strategic Importance - The biopharmaceutical industry in Beijing is projected to exceed 1 trillion yuan by 2024, indicating a significant growth trajectory supported by government initiatives aimed at fostering innovation [12]. - The case of Gene Enlightenment exemplifies the shift towards deep innovation in specific technological areas, which is essential for enhancing the global competitiveness of Beijing's biopharmaceutical sector [11][12].